Neumirna Therapeutics is a biotech company developing RNA-based therapies, focusing on an Antisense Oligonucleotide treatment for drug-resistant epilepsy.

Corteria Pharmaceuticals is a biopharmaceutical company that develops first-in-class therapies for unaddressed heart failure subpopulations, with a focus on multi-organ benefits targeting the kidneys, heart, and vessels.